2007Unpublished venueRequires access

Studies on bioequivalence of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride

HE Xiao-jing

Open publisher page 0 citations

Abstract

Objective To evaluate the bioequivalence of two kinds of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride.Methods Single doses of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride were administered orally in 20 volunteers in an open,randomized,and crossover study of the pharmacokinetics and bioequivalence,and plasma concentrations of cetirizine hydrochloride were determined with HPLC.Results The pharmacokinetic parameters of test and control preparations were as follows: Tmax(0.6±0.27) and(0.9±0.32) h;Cmax(644.5±108.4) and(654.1±102.4) ng·mL-1;t1/2(8.6±2.0) and(8.9±3.6) h;AUC0-t(4 944.3±750.4) and(5 128.9±991.4) ng·h·mL-1;AUC0-∞(5 535.8±941.1) and(5 868.7±1519.7) ng·h·mL-1.The relative bioavailability of test formulation was(98.1±14.9)%.The result of statistical analysis on above parameters showed that there was no significant difference between two preparations.Conclusion The two preparations were bioequivalent.

About this research paper

What this paper is about

Objective To evaluate the bioequivalence of two kinds of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride.Methods Single doses of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride were administered orally in 20 volunteers in an open,randomized,and crossover study of the pharmacokinetics and bioequivalence,and plasma concentrations of cetirizine hydrochloride were determined with HPLC.Results The pharmacokinetic parameters of test and control preparations were as follows: Tmax(0.6±0.27) and(0.9±0.32) h;Cmax(644.5±108.4) and(654.1±102.4) ng·mL-1;t1/2(8.6±2.0) and(8.9±3.6) h;AUC0-t(4 944.3±750.4) and(5 128.9±991.4) ng·h·mL-1;AUC0-∞(5 535.8±941.1) and(5 868.7±1519.7) ng·h·mL-1.The relative bioavailability of test formulation was(98.1±14.9)%.The result of statistical analysis on above parameters showed that there was no significant difference between two preparations.Conclusion The two preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the bioequivalence of two kinds of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride.Methods Single doses of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride were administered orally in 20 volunteers in an open,randomized,and crossover study of the pharmacokinetics and bioequivalence,and plasma concentrations of cetirizine hydrochloride were determined with HPLC.Results The pharmacokinetic parameters of test and control preparations were as follows: Tmax(0.6±0.27) and(0.9±0.32) h;Cmax(644.5±108.4) and(654.1±102.4) ng·mL-1;t1/2(8.6±2.0) and(8.9±3.6) h;AUC0-t(4 944.3±750.4) and(5 128.9±991.4) ng·h·mL-1;AUC0-∞(5 535.8±941.1) and(5 868.7±1519.7) ng·h·mL-1.The relative bioavailability of test formulation was(98.1±14.9)%.The result of statistical analysis on above parameters showed that there was no significant difference between two preparations.Conclusion The two preparations were bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Cmax, Pharmacokinetics, Pharmacology, Cetirizine, Chromatography, Crossover study

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on bioequivalence of orally disintegrating tablets and conventional tablets of cetirizine hydrochloride — Research Paper | ScholarLens